Improved method for synthesizing functionalized mercaptans

The synthesis of functionalized mercaptans using L-homocysteine and a sulfhydrylase enzyme under oxygen-free conditions addresses the selectivity and by-product issues of conventional methods, achieving high yields and reduced costs.

JP7591125B2Active Publication Date: 2024-11-27ARKEMA FRANCE SA
View PDF -1 Cites 0 Cited by

Patent Information

Application Number
JP2023504118
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-12-04
Filing Date
2021-07-13
Publication Date
2024-11-27
Estimated Expiration
2041-07-13

AI Technical Summary

Technical Problem

Conventional methods for synthesizing functionalized mercaptans, particularly those containing functional groups other than the thiol group, suffer from low selectivity and high formation of undesirable by-products like sulfides and polysulfides, leading to increased costs and purification challenges.

Method used

A method involving the reaction of L-homocysteine or L-homocysteine sulfide with a compound of formula (II) and hydrosulfide in the presence of a sulfhydrylase enzyme under oxygen-free conditions, limiting the formation of sulfides and polysulfides.

Benefits of technology

This method achieves yields of up to 100% functionalized mercaptans with minimal by-products, enhancing selectivity and reducing manufacturing costs by minimizing the formation of sulfides and polysulfides.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007591125000001
    Figure 0007591125000001
  • Figure 0007591125000002
    Figure 0007591125000002
  • Figure 0007591125000003
    Figure 0007591125000003
Patent Text Reader

Abstract

The present invention relates to a method for synthesizing functionalized mercaptans essentially in the absence of oxygen, and in particular to compositions that make it possible to carry out this method, said functionalized mercaptans being of formula (I): R2-XC * H(NR1R7)-(CH2) n -SH (I) During the ceremony, R1 and R7 are the same or different and each represents a hydrogen atom or a C1 to C20 aromatic or non-aromatic, linear, branched or cyclic, saturated or unsaturated hydrocarbon chain which may contain one or more heteroatoms; X is selected from —C(═O)—, —CH—, and —CN; R2 is (i) absent when X is -CN; (ii) is a hydrogen atom or (iii) -OR3, where R3 is a hydrogen atom or a linear, branched, or cyclic, saturated or unsaturated, aromatic or non-aromatic hydrocarbon chain having 1 to 20 carbon atoms, which may contain one or more heteroatoms; or (iv) -NR4R5, wherein R4 and R5 are the same or different and each is a hydrogen atom or a C1-20 aromatic or non-aromatic, linear, branched or cyclic, saturated or unsaturated hydrocarbon chain which may contain one or more heteroatoms; n is 1 or 2, * represents an asymmetric carbon.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a method for the synthesis of functionalized mercaptans and in particular also to a composition making it possible to carry out this method. [Background technology]

[0002] Mercaptans are used in many industrial sectors and many methods for their synthesis are known, including the sulfurization of alcohols, the catalytic or photochemical addition of hydrogen sulfide to unsaturated organic compounds, and the displacement of halides, epoxides, or organic carbonates with hydrogen sulfide.

[0003] However, these methods have many drawbacks and are not always suitable for the synthesis of functionalized mercaptans, i.e. mercaptans containing at least one functional group other than the thiol group (-SH). This type of mercaptans constitutes a chemical family with great potential, especially amino acids and derivatives with a thiol function, specifically homocysteine. Functionalized mercaptans can be useful, for example, as synthetic intermediates in the cosmetics industry. However, at present there is no efficient synthetic method suitable for the production of industrially viable functionalized mercaptans, especially for applications falling in the field of commodity chemicals.

[0004] For example, among conventional chemical methods, substitution with hydrogen sulfide often requires high temperatures and pressures, resulting in the undesirable by-products of olefins, ethers, sulfides and / or polysulfides. The catalytic or photochemical addition of hydrogen sulfide to unsaturated compounds is generally carried out under somewhat milder conditions, but similarly leads to the formation of many by-products by isomerization of the starting materials, non-regioselective addition, or double addition leading to the production of sulfides and / or polysulfides.

[0005] Thus, the main drawback of the conventional synthesis methods is that, together with the desired mercaptans, significant amounts of associated sulfides and / or polysulfides that are difficult to upgrade are produced. These side reactions increase the variable costs associated with the starting materials due to reduced selectivity and therefore yields, increase purification costs, and increase production costs due to the expensive destruction of the by-products.

[0006] The synthesis of functionalized mercaptans by biological routes is known as well as by chemical routes. For example, cysteine ​​is currently produced biologically by fermentation (Maier T., 2003. Nature Biotechnology, 21:422-427). The biological route is milder and more suitable for multifunctional molecules. However, even in this case, polysulfides such as the corresponding sulfides and / or disulfides are produced together with the desired mercaptan (WO 2012 / 053777).

[0007] There is therefore a need for improved methods for the synthesis of functionalized mercaptans, in particular by biological routes, which make it possible to limit or prevent the formation of by-products, in particular sulfides and / or polysulfides. There is also a need for methods for the synthesis of functionalized mercaptans that are safe and easy to implement industrially. Summary of the Invention [Problem to be solved by the invention]

[0008] The present invention makes it possible to overcome in whole or in part the drawbacks of the prior art methods.

[0009] One object of the present invention is to provide an improved process for the synthesis of functionalized mercaptans, in particular one that exhibits yields and / or selectivities comparable to or better than known processes.

[0010] One object of the present invention is to provide a process for the synthesis of functionalized mercaptans with negligible or no coproduction of by-products, specifically sulfides and / or polysulfides. [Means for solving the problem]

[0011] The inventors have found that a functionalized mercaptan of formula (I) as defined below (specifically L-homocysteine) can be advantageously synthesized by reacting a compound of formula (II) as defined below with a hydrosulfide salt and / or sulfide salt (hereinafter referred to as "salt") as defined below or with H2S in the presence of a sulfhydrylase enzyme, essentially in the absence of oxygen or in the absence of oxygen.

[0012] Thus, the inventors have found a method for the synthesis of functionalized mercaptans of formula (I) that makes it possible to limit or prevent the co-formation of sulfides and / or polysulfides (particularly disulfides).

[0013] More specifically, the method of the present invention allows for the production of L-homocysteine ​​while limiting or preventing the co-production of L-homocystine and / or L-homocysteine ​​sulfide (also known as 4,4'-sulfanediylbis(2-aminobutanoic acid) / L-homolantionine). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0014] L-homocysteine ​​has the formula: [ka]

[0015] L-homocysteine ​​sulfide has the formula: [ka]

[0016] L-homocystine has the formula: [ka]

[0017] It is also observed that the configuration of the asymmetric carbon atom is preserved throughout the reaction. Thus, the functionalized mercaptans of formula (I) obtained by the process of the present invention may be enantiopure.

[0018] The process according to the invention is also easy to carry out industrially. It can be carried out in solution under mild temperature and pressure conditions. The use of salts advantageously avoids the operator having to deal with hydrogen sulfide, a toxic gas.

[0019] The yield obtained can be 85% or more, preferably 90% or more, for example 90% to 100%. Surprisingly, the method according to the present invention allows in particular to obtain a yield of 100%, i.e. an increase of nearly 20% compared to other methods.

[0020] Thus, the present invention provides a method for the synthesis of at least one functionalized mercaptan of general formula (I): R2-XC * H(NR1R7)-(CH2) n -SH (I) [In the formula, R1 and R7 are the same or different and each is a hydrogen atom or a C1 to C20 aromatic or non-aromatic linear, branched or cyclic, saturated or unsaturated hydrocarbon chain which may contain one or more heteroatoms; X is selected from -C(=O)-, -CH2- and -CN; R2 is (i) absent when X is -CN; (ii) is a hydrogen atom, or (iii) -OR3, where R3 is a hydrogen atom or a linear, branched or cyclic, saturated or unsaturated, aromatic or non-aromatic hydrocarbon chain having 1 to 20 carbon atoms, which may contain one or more heteroatoms; or (iv) -NR4R5, wherein R4 and R5 are the same or different and each is a hydrogen atom or a C1-20 aromatic or non-aromatic linear, branched or cyclic, saturated or unsaturated hydrocarbon chain, which may contain one or more heteroatoms; n is 1 or 2, * represents an asymmetric carbon.] a) providing at least one compound of general formula (II): R2-XC * H(NR1R7)-(CH2) n -G (II) [In the formula, *, R1, R2, R7, X and n are as defined in formula (I); G represents (i) R6-C(O)-O-, (ii) (RO)(RO)-P(O)-O-, or (iii) RO-SO2-O-, where R6 is a hydrogen atom or may contain one or more aromatic groups, -OR 10 , (=O), -C(O)OR 11 , and -NR 12 R 13 R is a linear, branched or cyclic, saturated or unsaturated hydrocarbon chain having 1 to 20 carbon atoms, which may be substituted with one or more groups selected from 10 , R 11 , R 12 and R 13 are each independently H or a linear, branched or cyclic, saturated or unsaturated hydrocarbon chain having 1 to 20 carbon atoms; R7 and R8 are the same or different and each represents a proton, an alkali metal, an alkaline earth metal, or ammonium; R9 is selected from a proton, an alkali metal, an alkaline earth metal, and ammonium. b) providing at least one hydrosulfide salt and / or sulfide salt or H2S; c) reacting at least one compound of formula (II) with at least one hydrosulfide salt and / or sulfide salt or H2S in the presence of at least one enzyme selected from sulfhydrylases, preferably a sulfhydrylase associated with the compound of formula (II), essentially in the absence of oxygen, preferably in the absence of oxygen; d) obtaining at least one functionalized mercaptan of formula (I); e) optionally isolating the at least one functionalized mercaptan of formula (I) obtained in step d); f) optionally further functionalization and / or deprotection of the functionalized mercaptan of formula (I) obtained in step d) or e); Including, Steps a) and b) may be carried out simultaneously; It relates to synthesis methods.

[0021] Oxygen is understood to mean specifically O2.

[0022] Thus, step c) is carried out essentially in the absence of oxygen or in the absence of oxygen.

[0023] More specifically, "essentially in the absence of oxygen" is understood to mean that oxygen may remain in the reaction mixture and / or in the gas phase (contained in the gas headspace of the reactor) in such an amount that the amount of sulfides and / or polysulfides formed is 5% by weight or less, relative to the total weight of compounds of formula (I) formed.

[0024] Preferably, "essentially in the absence of oxygen" is understood to mean that the reaction mixture contains less than 0.0015% by weight (preferably strictly less than 0.0015% by weight) of oxygen relative to the total weight of the reaction mixture and / or that the gas phase (contained in the gas headspace of the reactor) contains less than 21% by volume (preferably strictly less than 21% by volume) of oxygen relative to the total volume of the gas phase.

[0025] Thus, step c) may be as follows: c) reacting at least one compound of formula (II) with at least one hydrosulfide salt and / or sulfide salt or H2S in the presence of at least one enzyme selected from sulfhydrylases, preferably a sulfhydrylase associated with a compound of formula (II), wherein the reaction is carried out in a reactor in which the reaction mixture contains from 0 to 0.0015% by weight (preferably strictly less than 0.0015% by weight) of oxygen relative to the total weight of the reaction mixture and / or in which the gas phase contained in the gas head space of the reactor contains from 0 to 21% by volume (preferably strictly less than 21% by volume) of oxygen relative to the total volume of the gas phase.

[0026] Specifically, the amount of oxygen in the reaction mixture and / or in the gas phase (contained in the gas headspace) is such that the amount of sulfides and / or polysulfides formed is 5% by weight or less, based on the total weight of the compounds of formula (I) formed.

[0027] For example, step c) can be carried out in a closed reactor (i.e. without oxygen supply from air). Very preferably, in particular when H2S is used, the gas phase (contained in the gas head space) is oxygen-free. Preferably, the gas phase (contained in the gas head space) is oxygen-free and the reaction mixture contains 0 to 0.0015% by weight (preferably strictly less than 0.0015% by weight) of oxygen relative to the total weight of the reaction mixture.

[0028] Indeed, O2 / H2S mixtures are potentially explosive and pose obvious safety risks to operators.

[0029] In particular, "gas headspace" is understood to mean the space above the reaction mixture in the reactor (preferably above the liquid reaction mixture). More particularly, "gas headspace" is understood to mean the space between the level of the liquid reaction mixture and the ceiling of the reactor (i.e. the upper part of the reactor, which contains the gas phase, if the lower part of the reactor contains a liquid phase). The gas headspace in particular contains the gas phase.

[0030] The reactants are typically introduced into the reactor in amounts such that a gas headspace is provided above the reaction mixture contained in the reactor.

[0031] Specifically, when H2S is used, a portion of the H2S is dissolved in the reaction mixture so that the reaction of step c) takes place, while the remainder of the H2S is disposed in gaseous form in the gas head space of the reactor.

[0032] More specifically, at least one compound of formula (II), at least one hydrosulfide salt and / or sulfide salt or H2S, and at least one sulfhydrylase form a reaction mixture (or medium). Thus, the reaction mixture comprises: At least one compound of formula (II) as defined below, at least one hydrosulfide salt and / or sulfide salt as defined below, or H2S, At least one sulfhydrylase as defined below; Optionally, a cofactor thereof, as defined below, Optionally, a base as defined below, Optionally, a solvent (preferably water), may include.

[0033] The reaction mixture can be prepared by adding the compound of formula (II), the hydrosulfide salt and / or sulfide salt or H2S, and the sulfhydrylase in any order.

[0034] For example, it is possible to first mix the compound of formula (II) with a salt or H2S and then add a sulfhydrylase, optionally with its cofactor, to initiate the reaction of step c).

[0035] It is the addition of a third component that allows the reaction to begin, whatever that may be, but in particular a sulfhydrylase.

[0036] Preferably, the compound of formula (II) is in the form of a solution, more preferably in the form of an aqueous solution.

[0037] Preferably, when hydrosulfide salts and / or sulfide salts are used, they are used in the form of a solution, more preferably in the form of an aqueous solution.

[0038] When H2S is used, it is usually in gaseous form. H2S can be introduced into the reaction mixture, specifically by bubbling. Bubbling can be carried out by mixing H2S with an inert gas, such as dinitrogen, argon or methane, preferably nitrogen. Thus, H2S can be present in the reaction mixture in dissolved form.

[0039] Conventional methods can be used to carry out step c) essentially in the absence of oxygen or in the absence of oxygen.

[0040] According to one embodiment, prior to step c), oxygen is removed from the reaction mixture, for example by degassing.

[0041] According to another embodiment, prior to step c), oxygen is removed separately from each of the components that will form the reaction mixture or from a mixture of at least two of these components, for example, each of the solution containing the compound of formula (II), the solution containing the hydrosulfide salt and / or the sulfide salt (if used), the solution containing the sulfhydrylase, and optionally the solvent, is degassed.

[0042] It is also possible to remove oxygen from the headspace of the reactor in which step c) is carried out, preferably by degassing.

[0043] The reactor can also be inerted with an inert gas (such as nitrogen, argon or methane, preferably nitrogen).

[0044] If H2S is used, of course degassing of this reactant is not performed since H2S is a gas and generally does not contain oxygen.

[0045] The various techniques may be combined with each other.

[0046] Preferably, the absence of oxygen is achieved in the following manner: The reactor is inerted with an inert gas (such as nitrogen, argon or methane, preferably nitrogen); Each of the solution containing the compound of formula (II), the solution containing the hydrosulfide salt and / or sulfide salt (if used), the solution containing the sulfhydrylase, and optionally the solvent, is degassed.

[0047] Industrial degassing methods are well known and include, for example: Decompression (vacuum degassing), Temperature adjustment (heating up for aqueous solvents, cooling down for organic solvents), Membrane degassing, Degassing by alternating freeze-pump-thaw cycles; Degassing by sparging with an inert gas (eg, argon, nitrogen or methane).

[0048] According to one embodiment, in step c), oxygen is neither present in dissolved form in the liquid (particularly in the reaction mixture) nor in gaseous form (particularly in the gaseous form in the headspace of the reactor in which step c) is carried out).

[0049] Preferably, the hydrosulfide salt and / or sulfide salt or H2S is in excess, preferably a molar excess, relative to the compound of formula (II), preferably during step c), more preferably for the entire duration of step c).

[0050] Thus, the hydrosulfide salt and / or sulfide salt or H2S may be in a superstoichiometric amount relative to the amount of compound of formula (II), preferably during step c), more preferably for the entire duration of step c).

[0051] Specifically, the molar ratio [hydrosulfide salt and / or sulfide salt] / [compound of formula (II)] or the molar ratio H2S / compound of formula (II) is preferably during step c), more preferably during the entire period of step c), from 1.5 to 10, preferably from 2 to 8, for example from 3.5 to 8, even more preferably from 3.5 to 5. The above ratio may be kept constant during the entire period of step c).

[0052] Step c) can be carried out in a solution, in particular in an aqueous solution, for example comprising 50% to 99% by weight of water, preferably 75% to 97% by weight of water relative to the total weight of the solution.

[0053] The pH of the reaction mixture in step c) may be from 4 to 9, for example from 5 to 8, preferably from 6 to 7.5, more particularly from 6.2 to 7.2, especially when the reaction mixture is an aqueous solution.

[0054] The pH can be adjusted within the above ranges, depending in particular on the operating optimum of the selected sulfhydrylase. The pH can be determined by methods known in the art, for example by using a pH probe.

[0055] According to a preferred embodiment, step c) may be carried out according to the following two steps c1) and c2): c1) reacting at least one compound of formula (II) with at least one hydrosulfide salt and / or sulfide salt or H2S in the presence of at least one enzyme selected from sulfhydrylases, preferably a sulfhydrylase associated with the compound of formula (II), in a solution essentially in the absence of oxygen, preferably in the absence of oxygen; c2) adjusting the pH of said solution by adding a base to obtain a pH between 4 and 9, for example between 5 and 8, preferably between 6 and 7.5, more particularly between 6.2 and 7.2.

[0056] In step c2) any base may be used, preferably a base containing a sulfur atom. The base is understood in particular to be a compound or mixture thereof having a pH of more than 7, preferably a pH of 8 to 14. The base may be selected from hydrosulfide salts and / or sulfide salts as defined below, sodium hydroxide, potassium hydroxide and ammonia. The base may be selected in particular from hydrosulfide salts and / or sulfide salts as defined below. Preferably, the base is a hydrosulfide salt and / or sulfide salt used in step c1). A preferred base is ammonium hydrosulfide (NH4SH).

[0057] The base may be added at a concentration of 0.1 to 10 M, preferably 0.5 to 10 M, more preferably 0.5 to 5 M. In particular, a concentrated base is used to limit dilution of the reaction mixture upon addition of the base.

[0058] The temperature during step c) may be between 10°C and 60°C, preferably between 20°C and 40°C, more particularly between 25°C and 40°C. The pressure during step c) is generally atmospheric pressure. Step c) may be carried out batchwise, semi-continuously or continuously. Any type of reactor may be suitable.

[0059] The separation step e) can be carried out by any technique known to the person skilled in the art. In particular, if the final product is a solid: by extraction and / or decantation with a solvent immiscible in the reaction medium, followed by evaporation of the solvent; This is done by precipitation (by partial evaporation of the solvent or by addition of a solvent in which the target compound is poorly soluble). Precipitation is generally followed by a filtration step according to any method known to those skilled in the art. The final product can then be dried; or This is achieved by selective precipitation by adjusting the pH as a function of the solubility of each compound.

[0060] The homocysteine ​​may specifically be recovered in solid form.

[0061] If the final product is in liquid form, separation can be carried out by distillation or by liquid / liquid extraction followed by distillation or evaporation.

[0062] Step f), further functionalization and / or optional deprotection, makes it possible to obtain further chemical functions and / or to deprotect certain chemical functions by conventional methods. For example, if X-R2 represents a carboxyl function, the latter can be esterified, reduced to an aldehyde, reduced to an alcohol followed by esterification, amidation, nitrification, etc. The skilled person is able to obtain and / or deprotect any functional group depending on the final application intended for the functionalized mercaptan of formula (I).

[0063] Thus, the functionalized mercaptan of formula (I) obtained as a result of step d) or e) may be subjected to one or more further chemical reactions well known to those skilled in the art in order to obtain mercaptan derivatives having one or more different functional groups.

[0064] The expression "from X to X" includes the limits mentioned, unless otherwise specified.

[0065] Heteroatoms are understood in particular to be atoms selected from O, N, S, P and the halogens.

[0066] An unsaturated hydrocarbon chain is understood to be a hydrocarbon chain which contains at least one double or triple bond between two carbon atoms.

[0067] Functionalized mercaptans of general formula (I): The process according to the invention aims at obtaining functionalized mercaptans of general formula (I): R2-XC * H(NR1R7)-(CH2) n -SH (I) During the ceremony, R1 and R7 are the same or different and each is a hydrogen atom or a C1 to C20 aromatic or non-aromatic linear, branched or cyclic, saturated or unsaturated hydrocarbon chain which may contain one or more heteroatoms; X is selected from -C(=O)-, -CH2- and -CN; R2 is (i) absent when X is -CN; (ii) is a hydrogen atom, or (iii) -OR3, where R3 is a hydrogen atom or a linear, branched or cyclic, saturated or unsaturated, aromatic or non-aromatic hydrocarbon chain having 1 to 20 carbon atoms, which may contain one or more heteroatoms; or (iv) -NR4R5, wherein R4 and R5 are the same or different and each is a hydrogen atom or a C1-20 aromatic or non-aromatic linear, branched or cyclic, saturated or unsaturated hydrocarbon chain, which may contain one or more heteroatoms; n is 1 or 2, * represents an asymmetric carbon.

[0068] The above mercaptans are referred to as functionalized because, in addition to the chemical functionality -SH, they also contain at least one amine functionality -NR1R7.

[0069] Preferably, n is 2.

[0070] Preferably, X is -C(=O)-.

[0071] Preferably, R2 is OR3, and R3 is as defined above. Specifically, R3 may be a hydrogen atom or a linear or branched saturated hydrocarbon chain having 1 to 10 carbon atoms (preferably 1 to 5 carbon atoms). Specifically, R3 is H.

[0072] R1 and R7 are the same or different, and each is preferably a hydrogen atom or a linear or branched saturated hydrocarbon chain having 1 to 10 carbon atoms (preferably 1 to 5 carbon atoms). Preferably, R1 and R7 are each H.

[0073] Specifically, X is -C(=O)-, R2 is -OR3, and R3 is as defined above.

[0074] The functionalized mercaptan of formula (I) may be selected from the group consisting of homocysteine, cysteine, and derivatives thereof.

[0075] Specifically, the functionalized mercaptan of formula (I) is L-homocysteine ​​or L-cysteine.

[0076] A preferred functionalized mercaptan of formula (I) is homocysteine, specifically L-homocysteine ​​of the following formula: [ka]

[0077] In the case of L-homocysteine, n is 2, X is -C(=O)-, R2 is -OR3, R3 is H, and R1 and R7 are each H.

[0078] The functionalized mercaptan of formula (I) is a chiral compound. It can be obtained in enantiopure form by the process according to the invention. In the present specification, if the enantiomeric form is not specified, the compound is included in whatever form it may be.

[0079] According to one embodiment, the reaction mixture at the end of step c) does not contain any sulfides or polysulfides, in particular any sulfides or polysulfides corresponding to the functionalized mercaptan of formula (I) obtained. For example, the reaction mixture at the end of step c) contains less than 10 mol % (preferably less than 5 mol %) of sulfides and polysulfides relative to the total number of moles of the compound of formula (II) converted to the compound of formula (I).

[0080] Sulfides are understood in particular to be sulfides of the following formula (III) which correspond to the compounds of formula (I): R2-XC * H(NR1R7)-(CH2) n -S-(CH2) n -(NR1R7)C * HX-R2(III) In the formula, *, R1, R2, R7, X and n are as defined above.

[0081] The polysulfides are in particular understood to be polysulfides of the following formula (IV) which correspond to the compounds of formula (I): R2-XC * H(NR1R7)-(CH2) n -(S) m -(CH2) n -(NR1R7)C * HX-R2(IV) In the formula, *, R1, R2, R7, X and n are as defined above, and m is an integer of 2 to 6, for example, m is 2 or 3.

[0082] Preferably, m is 2 (corresponding to a disulfide).

[0083] Specifically, when the compound of formula (I) is L-homocysteine, the reaction mixture at the end of step c) does not contain L-homocysteine ​​sulfide or L-homocystine.

[0084] Preferably, after the reaction of the compound of formula (II) with at least one hydrosulfide salt and / or sulfide salt or H2S in step c), a functionalized mercaptan of formula (I) as defined below and a compound of formula (V) GH, where G is as defined above, i.e. (i') R6-C(O)-OH, (ii') (RO)(RO)-P(O)-OH, or (iii') RO-SO2-OH, where R6, R7, R8 and R9 are as defined below, are obtained. In particular, when compound (II) is O-acetyl-L-homoserine, L-homocysteine ​​and acetic acid are obtained. The compound of formula (V) may acidify the reaction mixture in step c). Thus, in particular during the above-mentioned step c), it is possible to maintain the pH of the reaction mixture between 4 and 9, for example between 5 and 8, preferably between 6 and 7.5, more particularly between 6.2 and 7.2, in particular by adding a base as defined above.

[0085] Hydrosulfide and / or sulfide salts or H2S: The present invention can be carried out in the presence of hydrosulfide and / or sulfide salts or in the presence of H2S (hydrogen sulfide).

[0086] The above salts are generally provided in the form of a solution, preferably an aqueous solution.

[0087] The at least one hydrosulfide salt and / or sulfide salt may be selected from the group consisting of ammonium hydrosulfide, alkali metal hydrosulfide, alkaline earth metal hydrosulfide, alkali metal sulfide and alkaline earth metal sulfide.

[0088] Alkali metals are understood to be lithium, sodium, potassium, rubidium and cesium, preferably sodium and potassium.

[0089] Alkaline earth metals are understood to be beryllium, magnesium, calcium, strontium and barium, preferably calcium.

[0090] Specifically, the at least one hydrosulfide salt and / or sulfide salt may be selected from the group consisting of ammonium hydrosulfide NH4SH, sodium hydrosulfide NaSH, potassium hydrosulfide KSH, calcium hydrosulfide Ca(SH)2, sodium sulfide Na2S, ammonium sulfide (NH4)2S, potassium sulfide K2S and calcium sulfide CaS. A preferred hydrosulfide is ammonium hydrosulfide NH4SH.

[0091] The ammonium released during the reaction can be reused, for example, as a nitrogen source for the growth of a microorganism, in particular a microorganism expressing or overexpressing sulfhydrylase. For example, the microorganism can be selected from the group consisting of bacterial cells such as Escherichia coli or Bacillus sp. or Pseudomonas, yeast cells such as Saccharomyces cerevisiae or Pichia pastoris, fungal cells such as Aspergillus niger, Penicillium funiculosum or Trichoderma reesei, insect cells such as Sf9 cells, or mammalian (in particular human) cells such as HEK293, PER-C6 or CHO cell lines. More specifically, bacterial cells are used, more preferably Escherichia coli cells.

[0092] Compounds of general formula (II): Regarding the compound of the following general formula (II): R2-XC* H(NR1R7)-(CH2) n -G (II) During the ceremony, *, R1, R2, R7, X and n are as defined in the compound of formula (I); G represents (i) R6-C(O)-O-, (ii) (RO)(RO)-P(O)-O-, or (iii) RO-SO2-O-, where R6 is a hydrogen atom or may contain one or more aromatic groups, -OR 10 , (=O), -C(O)OR 11 , and -NR 12 R 13 R is a linear, branched or cyclic, saturated or unsaturated hydrocarbon chain having 1 to 20 carbon atoms (preferably 1 to 10 carbon atoms) which may be substituted with one or more groups selected from 10 , R 11 , R 12 and R 13 each independently represents H or a linear, branched or cyclic, saturated or unsaturated hydrocarbon chain having 1 to 20 carbon atoms (preferably 1 to 10 carbon atoms); R7 and R8 are the same or different and each represents a proton, an alkali metal, an alkaline earth metal, or ammonium (preferably a proton or an alkali metal, more preferably H + or Na + ) and R9 is a proton, an alkali metal, an alkaline earth metal, and ammonium (preferably a proton and an alkali metal, more preferably a proton H + and Na + ) is selected.

[0093] In particular, G represents either R6-C(O)-O- or R9O-SO2-O-, preferably G is R6-C(O)-O-.

[0094] In particular, R6 is a hydrogen atom or -OR 10 , (=O), and -C(O)OR 11 [R 10 and R11 are each independently selected from H, or a linear or branched, saturated or unsaturated hydrocarbon chain having 1 to 10 carbon atoms (preferably 1 to 5 carbon atoms) which may be substituted with one or more groups selected from

[0095] More specifically, R 10 and R 11 are H. Specifically, R 12 and R 13 are H, respectively.

[0096] An aromatic group is understood to be preferably a phenyl group.

[0097] The compound of general formula (II) is specifically a derivative of serine (when n is 1) or a derivative of homoserine (when n is 2), specifically a derivative of L-serine or a derivative of L-homoserine. The compound of general formula (II) may, for example, be selected from the group consisting of O-phospho-L-homoserine, O-succinyl-L-homoserine, O-acetyl-L-homoserine, O-acetoacetyl-L-homoserine, O-propio-L-homoserine, O-coumaroyl-L-homoserine, O-malonyl-L-homoserine, O-hydroxymethylglutaryl-L-homoserine, O-pimelyl-L-homoserine, O-sulfato-L-homoserine, O-phospho-L-serine, O-succinyl-L-serine, O-acetyl-L-serine, O-acetoacetyl-L-serine, O-propio-L-serine, O-coumaroyl-L-serine, O-malonyl-L-serine, O-hydroxymethylglutaryl-L-serine, O-pimelyl-L-serine and O-sulfato-L-serine.

[0098] More specifically, the compound of general formula (II) may be selected from the group consisting of O-phospho-L-homoserine, O-succinyl-L-homoserine, O-acetyl-L-homoserine, O-acetoacetyl-L-homoserine, O-propio-L-homoserine, O-coumaroyl-L-homoserine, O-malonyl-L-homoserine, O-hydroxymethylglutaryl-L-homoserine, O-pimelyl-L-homoserine and O-sulfato-L-homoserine.

[0099] The compound of general formula (II) may be selected from the group consisting of O-phospho-L-homoserine, O-succinyl-L-homoserine, O-acetyl-L-homoserine, O-sulfato-L-homoserine and O-propio-L-homoserine.

[0100] The compound of general formula (II) may be selected from the group consisting of O-phospho-L-homoserine, O-succinyl-L-homoserine and O-acetyl-L-homoserine.

[0101] A highly preferred compound of formula (II) is O-acetyl-L-homoserine (OAHS), which is the compound where n is 2, X is -C(=O)-, R2 is -OR3, R3 is H, R1 and R7 are each H, G is -OC(O)-R6, and R6 is methyl.

[0102] Compounds of formula (II) are either commercially available or may be obtained by any technique known to those skilled in the art.

[0103] The compound of formula (II) may be obtained by a fermentation process from a hydrocarbon and a nitrogen source, for example as described in WO 2008 / 013432.

[0104] The compounds of formula (II) may be obtained, for example, by fermentation of renewable starting materials, which may be selected from glucose, sucrose, starch, molasses, glycerol and bioethanol, preferably glucose.

[0105] L-serine derivatives may also be produced by acetylation of L-serine, which itself can be obtained by fermentation of renewable starting materials, which may be selected from glucose, sucrose, starch, molasses, glycerol and bioethanol, preferably glucose.

[0106] L-homoserine derivatives may also be produced by acetylation of L-homoserine, which itself can be obtained by fermentation of renewable starting materials, which may be selected from glucose, sucrose, starch, molasses, glycerol and bioethanol, preferably glucose.

[0107] Sulfhydrylase: The reaction of the at least one compound of formula (II) with at least one hydrosulfide salt and / or sulfide salt or H2S as defined above is carried out in the presence of at least one enzyme selected from sulfhydrylases, preferably sulfhydrylases related to the compound of formula (II). The sulfhydrylases related to the compound of formula (II) are easily identifiable because they share similar names. For example, O-acetyl-L-homoserine sulfhydrylase (OAHS sulfhydrylase) is related to O-acetyl-L-homoserine.

[0108] Sulfhydrylase can in particular catalyze the reaction of the compound of formula (II) with the above salt or H2S. A "catalyst" is generally understood to be a substance that promotes a reaction and is unchanged at the end of the reaction. Sulfhydrylase and optionally its cofactors can be used in catalytic amounts. A "catalytic amount" is specifically understood to be an amount sufficient to catalyze a reaction. More specifically, a reagent used in a catalytic amount is used in a smaller amount relative to the weight of the reagent used in stoichiometric ratio, for example about 0.01% to 20% by weight.

[0109] The sulfhydrylase enzyme preferably belongs to the transferases, in particular classified in EC2.XXXX (or EC2). The EC classification of Enzyme Commission numbers is widely used and can be found on the website https: / / enzyme.expasy.org / . In particular, the sulfhydrylase enzyme is selected from the sulfhydrylases of the EC2.5.X.XX class (or EC2.5.), which means transferases that transfer alkyl or aryl groups other than methyl groups.

[0110] Sulfhydrylases are particularly of the EC class 2.5.1.XX, where XX varies depending on the substrate of the enzyme.

[0111] for example: O-acetylhomoserine sulfhydrylase is of the EC 2.5.1.49 type. O-phosphoserine sulfhydrylase is of the EC 2.5.1.65 type. O-Succinylhomoserine sulfhydrylase is of the EC 2.5.1.49 type.

[0112] for example: O-acetyl-L-homoserine sulfhydrylase is of the EC 2.5.1.49 type. O-phospho-L-serine sulfhydrylase is of the EC 2.5.1.65 type. O-Succinyl-L-homoserine sulfhydrylase is of the EC 2.5.1.49 type.

[0113] Thus, in particular when the compound of formula (II) is a derivative of L-homoserine or a derivative of L-serine, the sulfhydrylase used may be O-phospho-L-homoserine sulfhydrylase, O-succinyl-L-homoserine sulfhydrylase, O-acetyl-L-homoserine sulfhydrylase, O-acetoacetyl-L-homoserine sulfhydrylase, O-propio-L-homoserine sulfhydrylase, O-coumaroyl-L-homoserine sulfhydrylase, O-malonyl-L-homoserine sulfhydrylase, O-hydroxymethylglutaryl-L-homoserine sulfhydrylase, O-pimelyl-L-homoserine sulfhydrylase, O-amino ... The enzyme may be selected from moselin sulfhydrylase, O-sulfato-L-homoserine sulfhydrylase, O-phospho-L-serine sulfhydrylase, O-succinyl-L-serine sulfhydrylase, O-acetyl-L-serine sulfhydrylase, O-acetoacetyl-L-serine sulfhydrylase, O-propio-L-serine sulfhydrylase, O-coumaroyl-L-serine sulfhydrylase, O-malonyl-L-serine sulfhydrylase, O-hydroxymethylglutaryl-L-serine sulfhydrylase, O-pimelyl-L-serine sulfhydrylase and O-sulfatoserine sulfhydrylase.

[0114] In particular, the sulfhydrylase used may be selected from O-phospho-L-homoserine sulfhydrylase, O-succinyl-L-homoserine sulfhydrylase, O-acetyl-L-homoserine sulfhydrylase, O-acetoacetyl-L-homoserine sulfhydrylase, O-propio-L-homoserine sulfhydrylase, O-coumaroyl-L-homoserine sulfhydrylase, O-malonyl-L-homoserine sulfhydrylase, O-hydroxymethylglutaryl-L-homoserine sulfhydrylase, O-pimelyl-L-homoserine sulfhydrylase, and O-sulfato-L-homoserine sulfhydrylase.

[0115] In particular, the sulfhydrylase may be selected from O-phospho-L-homoserine sulfhydrylase, O-succinyl-L-homoserine sulfhydrylase, O-acetyl-L-homoserine sulfhydrylase, O-sulfato-L-homoserine sulfhydrylase and O-propio-L-homoserine sulfhydrylase.

[0116] The sulfhydrylase may be selected from O-phospho-L-homoserine sulfhydrylase, O-succinyl-L-homoserine sulfhydrylase and O-acetyl-L-homoserine sulfhydrylase.

[0117] Particularly preferably, the enzyme is O-acetyl-L-homoserine sulfhydrylase (OAHS sulfhydrylase).

[0118] Sulfhydrylase, specifically O-acetyl-L-homoserine sulfhydrylase, may originate or be derived from the following bacterial strains: Pseudomonas sp., Chromobacterium sp., Leptospira sp., and Hyphomonas sp.

[0119] Sulfhydrylases can function in the presence of a cofactor, such as pyridoxal 5'-phosphate (also known as PLP) or one of its analogues, preferably pyridoxal 5'-phosphate, as is well known to those of skill in the art.

[0120] As an analogue of the cofactor pyridoxal phosphate, α 5 -Pyridoxal methyl phosphate, 5'-methylpyridoxal-P, pyridoxal 5'-sulfate, α 5 -pyridoxaloacetic acid or any other known derivatives may be mentioned (Groman et al., Proc. Nat. Acad. Sci. USA Vol. 69, No. 11, pp. 3297-3300, November 1972).

[0121] According to one embodiment, a cofactor of sulfhydrylase can be added to the reaction mixture. Thus, the cofactor of sulfhydrylase (e.g., pyridoxal 5'-phosphate) can be provided before step c) or added during step c). If step c) is carried out in an aqueous solution, the enzyme and optionally its cofactor can be pre-dissolved in water before being added to the solution.

[0122] According to another embodiment, the cell (e.g., a bacterial cell or other cell) can produce or overproduce the cofactor while co-expressing or overexpressing the sulfhydrylase enzyme, so as to avoid the step of replenishing the cofactor.

[0123] According to one embodiment, the sulfhydrylase and optionally its cofactors are: in isolated and / or purified form, for example in an aqueous solution (isolation and / or purification of the produced enzyme can be carried out by any means known to the skilled artisan, which may include, for example, techniques selected from electrophoresis, molecular sieving, ultracentrifugation, differential precipitation, for example with ammonium sulfate, ultrafiltration, membrane or gel filtration, ion exchange, separation by hydrophobic interactions or affinity chromatography, for example of the IMAC type); or It is present in a crude extract, i.e. an extract (lysate) of milled cells (the enzyme of interest may or may not be overexpressed in a cell, hereinafter referred to as the host cell. The host cell may be any host cell suitable for producing the enzyme of interest from the expression of the corresponding coding gene. This gene is located in the genome of the host or carried by an expression vector).

[0124] For the purposes of the present invention, a "host cell" is understood to be, in particular, a prokaryotic or eukaryotic cell. Host cells commonly used for the expression of recombinant or non-recombinant proteins include, in particular, bacterial cells such as Escherichia coli or Bacillus sp. or Pseudomonas, yeast cells such as Saccharomyces cerevisiae or Pichia pastoris, fungal cells such as Aspergillus niger, Penicillium funiculosum or Trichoderma reesei, insect cells such as Sf9 cells, or mammalian (in particular human) cells such as HEK293, PER-C6 or CHO cell lines.

[0125] Preferably, the enzyme of interest and optionally its cofactors are expressed in E. coli. Preferably, the enzyme of interest is expressed in a strain of E. coli, such as the strain E. coli BL21(DE3).

[0126] Cell lysates can be obtained by various known techniques such as sonication, pressure (French press), use of chemical agents (e.g. xylene, Triton), etc. The resulting lysate represents a crude extract of the disrupted cells. Alternatively, it may be present in whole cells. For this, techniques similar to those described above may be used without performing a cell lysis step.

[0127] According to one embodiment, the amount of biomass expressing the sulfhydrylase enzyme relative to the mass of the compound of formula (II) is between 0.1% and 10% by weight (preferably between 1% and 5% by weight) and / or the amount of cofactor relative to the compound of formula (II) is between 0.1% and 10% by weight (preferably between 0.5% and 5% by weight).

[0128] The reaction mixture also Optionally, one or more solvents selected from a buffer such as water, phosphate buffer, Tris-HCl, Tris base, ammonium bicarbonate, ammonium acetate, HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), CHES (N-cyclohexyl-2-aminoethanesulfonic acid), or a salt such as sodium chloride, potassium chloride, or a mixture thereof; Optionally, additives such as surfactants, particularly to facilitate solubility of one or more reagents or substrates; may also include

[0129] The various components that can be used in the reaction of step c) above are readily commercially available or can be prepared by techniques well known to those skilled in the art. These various elements can be in solid, liquid or gaseous form and, very advantageously, can be in solution or dissolved in water or any other solvent used in the method of the invention. The enzymes used can be grafted to a support (in the case of supported enzymes).

[0130] According to a preferred embodiment, the compound of formula (II) is O-acetyl-L-homoserine, the enzyme used is O-acetyl-L-homoserine sulfhydrylase and the resulting functionalized mercaptan of formula (I) is L-homocysteine.

[0131] According to a preferred embodiment, the compound of formula (II) is O-acetyl-L-homoserine, the salt is ammonium hydrosulfide, the enzyme used is O-acetyl-L-homoserine sulfhydrylase and the resulting functionalized mercaptan of formula (I) is L-homocysteine.

[0132] The present invention also provides A compound of formula (II) as defined above, a sulfhydrylase as defined above, preferably a sulfhydrylase associated with a compound of formula (II), an excess of a hydrosulfide salt and / or sulfide salt as defined above or H2S (preferably an excess of NH4SH); The present invention relates to a composition, preferably an aqueous solution, comprising:

[0133] Preferably, the composition comprises: O-acetyl-L-homoserine, O-acetyl-L-homoserine sulfhydrylase, Excess NH4SH or H2S, Includes.

[0134] Said composition specifically corresponds to the reaction mixture defined above.

[0135] The conditions, properties and optional additional components are the same as those defined for the reaction mixture defined above.

[0136] In particular, the composition according to the present invention does not contain dissolved oxygen.Preferably, the hydrosulfide salt and / or sulfide salt or H2S is in excess relative to the compound of formula (II), preferably in molar excess.Therefore, the hydrosulfide salt and / or sulfide salt or H2S may be in a superstoichiometric amount relative to the amount of the compound of formula (II).

[0137] Specifically, the molar ratio [hydrosulfide salt and / or sulfide salt] / [compound of formula (II)] or the molar ratio H2S / compound of formula (II) is 1.5 to 10, preferably 2 to 8, for example 3.5 to 8, and even more preferably 3.5 to 5.

[0138] The composition may also comprise a cofactor for the sulfhydrylase defined above.

[0139] In particular, the composition according to the invention makes it possible to carry out the method according to the invention.

[0140] Working Example The following examples are intended to illustrate the invention but are not limiting in any way.

[0141] The usual definitions of conversion, selectivity and yield are as follows: Conversion rate = (moles of initial reactants - moles of reactants remaining after reaction) / (moles of initial reactants) Selectivity = moles of reactant converted to desired product / (moles of initial reactant - moles of reactant remaining after reaction) Yield = Conversion x Selectivity

[0142] Example 1: Comparative synthesis process of L-homocysteine ​​in the presence of oxygen and in the presence of stoichiometric amount of NaSH relative to OAHS.

[0143] Process 1 O-Acetyl-L-homoserine was synthesized from L-homoserine and acetic anhydride according to the protocol described in "Synthesis of O-acetyl-L-homoserine" by Sadamu Nadai, Academic Press (1971), vol. 17, pp. 423-424.

[0144] Process 2 5.25 g / l of O-acetyl-L-homoserine obtained in step 1) (this product is dissolved in 140 ml of water) are introduced into a thermostatically controlled 250 ml glass reactor. The solution is brought to 37° C. with mechanical stirring. A stoichiometric amount of NaSH dihydrate (i.e. 3 g / l) is then added to the reactor. The pH of the reaction medium is adjusted to a value of 6.5 with aqueous ammonia (4 M), then 5 g / l of OAHS sulfhydrylase and 0.4 g / l of pyridoxal phosphate cofactor are added to the reaction mixture. The pH is maintained at a set value of 6.5 with aqueous ammonia (4 M).

[0145] Potentiometric titration, HPLC, and NMR analyses show that over time the reagents (OAHS and NaSH) are gradually consumed and several products are gradually formed. The main compounds formed are: L-homocysteine, L-homocysteine ​​sulfide (4,4'-sulfanediylbis(2-aminobutanoic acid) / L-homolantionine), and L-Homocystine (disulfide / L-4,4'-dithiobis(2-aminobutanoic acid)).

[0146] Analysis of the reaction medium at the final time point showed that no traces of OAHS were detectable, indicating that all of the OAHS had been consumed by the end of the reaction.

[0147] The molar selectivities obtained for the converted OAHS (i.e. expressed as mole % of the various compounds present in the final mixture excluding water, acetic acid, and the PLP cofactor) are as follows: 31% L-homocysteine, and 69% homocysteine ​​sulfide (L-homolantionine / 4,4'-sulfanediylbis(2-aminobutanoic acid)) and homocystine (disulfide / L-4,4'-dithiobis(2-aminobutanoic acid)).

[0148] The molar yield of L-homocysteine ​​is 31%.

[0149] Example 2: Comparative synthesis process of L-homocysteine ​​in the presence of oxygen and in the presence of superstoichiometric amounts of NaSH relative to OAHS.

[0150] Process 1 O-Acetyl-L-homoserine was synthesized from L-homoserine and acetic anhydride according to the protocol described in "Synthesis of O-acetyl-L-homoserine" by Sadamu Nadai, Academic Press (1971), vol. 17, pp. 423-424.

[0151] Process 2 5.25 g / l of O-acetyl-L-homoserine obtained in step 1) (this product is dissolved in 140 ml of water) are introduced into a thermostatically controlled 250 ml glass reactor. The solution is brought to 37° C. with mechanical stirring. A superstoichiometric amount of NaSH dihydrate (×5, i.e. 15 g / l) is then added to the reactor. The pH of the reaction medium is adjusted to a value of 6.5, then 5 g / l of OAHS sulfhydrylase and 0.4 g / l of pyridoxal phosphate cofactor are added to the reaction mixture. The pH is maintained at a set value of 6.5 using aqueous ammonia solution (4 M).

[0152] Potentiometric, HPLC, and NMR analyses show that OAHS is gradually consumed over time and several products are gradually formed. The main compounds formed are L-homocysteine ​​and a significant proportion of L-homocystine (L-4,4'-dithiobis(2-aminobutanoic acid)).

[0153] In these tests, homocysteine ​​sulfide (L-homolanthionine) is not formed, since even traces of it cannot be detected in the final reaction medium.

[0154] Analysis of the reaction mixture at the final time point showed that no traces of OAHS were detectable, indicating that all of the OAHS had been consumed by the end of the reaction.

[0155] The molar selectivities obtained for the converted OAHS (calculated according to Example 1) are as follows: 80% L-Homocysteine 20% L-homocystine (L-4,4'-dithiobis(2-aminobutanoic acid)).

[0156] The molar yield of the above reaction calculated as L-homocysteine ​​is 80%.

[0157] Example 3: Synthesis process of L-homocysteine ​​in the absence of oxygen and in the presence of superstoichiometric amount of NaSH relative to OAHS according to the present invention

[0158] Process 1 O-Acetyl-L-homoserine was synthesized from L-homoserine and acetic anhydride according to the protocol described in "Synthesis of O-acetyl-L-homoserine" by Sadamu Nadai, Academic Press (1971), vol. 17, pp. 423-424.

[0159] Process 2 The solutions of OAHS, NaSH, and OAHS sulfhydrylase, and water are pre-degassed separately (before mixing) by nitrogen sparging at the reaction temperature to exclude dissolved oxygen. The reactor is also inerted under nitrogen.

[0160] Process 3 5.25 g / l of O-acetyl-L-homoserine obtained in step 1) (this product is dissolved in 140 ml of water) are introduced into a thermostatically controlled 250 ml glass reactor. The solution is brought to 37° C. with mechanical stirring. A superstoichiometric amount of NaSH dihydrate (×5, i.e. 15 g / l) is then added to the reactor. The pH of the reaction medium is adjusted to a value of 6.5, then 5 g / l of OAHS sulfhydrylase and 0.4 g / l of pyridoxal phosphate cofactor are added to the reaction mixture. The pH is maintained at a set value of 6.5 using aqueous ammonia solution (4 M).

[0161] Potentiometric titration, HPLC, and NMR analyses show the gradual consumption of OAHS and the gradual production of L-homocysteine. In these studies, homocysteine ​​sulfide (L-homolantionine) and disulfide (L-homocystine) are not formed and are not detectable in the final reaction mixture.

[0162] Analysis of the reaction mixture at the final time point showed that no traces of OAHS were detectable, indicating that all of the OAHS had been consumed by the end of the reaction.

[0163] Approximately 100% yield of L-homocysteine ​​is obtained. [Note] The present disclosure relates to the following aspects: <1> ~ <10> Also includes. <1> 1. A method for synthesizing at least one functionalized mercaptan of general formula (I): R 2 -XC * H(NR 1 R 7 )-(CH 2 ) n -SH (I) [In the formula, R 1 and R 7 are the same or different, and each is a hydrogen atom or a C1 to C20 aromatic or non-aromatic linear, branched or cyclic, saturated or unsaturated hydrocarbon chain which may contain one or more heteroatoms, X is -C(=O)-, -CH 2 -CN; R 2 teeth, (i) absent when X is -CN; (ii) is a hydrogen atom, or (iii)-OR 3 Is it R 3 is a hydrogen atom or a C1-20 aromatic or non-aromatic linear, branched or cyclic, saturated or unsaturated hydrocarbon chain, which may contain one or more heteroatoms; or (iv)-NR 4 R 5 and [R 4 and R 5 are the same or different and each is a hydrogen atom or a C1 to C20 aromatic or non-aromatic linear, branched or cyclic, saturated or unsaturated hydrocarbon chain which may contain one or more heteroatoms; n is 1 or 2, * represents an asymmetric carbon.] a) providing at least one compound of general formula (II): R 2 -XC * H(NR 1 R 7 )-(CH 2 ) n -G (II) [In the formula, *、R 1 、R 2 、R 7 , X and n are as defined in formula (I), G is (i) R 6 -C(O)-O-, (ii) (R 7 O)(R 8 O)-P(O)-O-, or (iii) R 9 O-SO 2 -O-, [R 6 is a hydrogen atom or may contain one or more aromatic groups, -OR 10 , (=O), -C(O)OR 11 , and -NR 12 R 13 R is a linear, branched or cyclic, saturated or unsaturated hydrocarbon chain having 1 to 20 carbon atoms, which may be substituted with one or more groups selected from 10 、R 11 、R 12 and R 13 are each independently H or a linear, branched or cyclic, saturated or unsaturated hydrocarbon chain having 1 to 20 carbon atoms; R 7 and R 8 are the same or different and each is a proton, an alkali metal, an alkaline earth metal, or ammonium, R 9 is selected from a proton, an alkali metal, an alkaline earth metal, and ammonium. b) at least one hydrosulfide salt and / or sulfide salt or H 2 providing S; c) reacting said at least one compound of formula (II) with said at least one hydrosulfide salt and / or sulfide salt or H 2 S in the presence of at least one enzyme selected from sulfhydrylases (preferably sulfhydrylases associated with the compound of formula (II) above) essentially in the absence of oxygen (preferably in the absence of oxygen); d) obtaining at least one functionalized mercaptan of formula (I); e) optionally isolating the at least one functionalized mercaptan of formula (I) obtained in step d); f) optionally further functionalizing and / or deprotecting said functionalized mercaptan of formula (I) obtained in step d) or e); Including, Steps a) and b) may be carried out simultaneously; Synthesis method. <2> Step c) The reaction mixture is carried out in a reactor containing less than 0.0015% by weight of oxygen based on the total weight of the reaction mixture; and / or carried out in a reactor in which the gas phase contained in the gas head space of the reactor contains less than 21% by volume of oxygen relative to the total volume of the gas phase, <1> The synthesis method described in <3> The hydrosulfide salt and / or sulfide salt or H 2 S is in excess relative to said compound of formula (II) (preferably during step c)), <1> The synthesis method described in <4> the molar ratio [hydrosulfide salt and / or sulfide salt] / [compound of formula (II)], or the molar ratio H 2 S / compound of formula (II) is (preferably during step c)) 1.5 to 10 (preferably 2 to 8, even more preferably 3.5 to 5), <1> or <2> The synthesis method described in <5> the at least one hydrosulfide salt and / or sulfide salt is selected from the group consisting of ammonium hydrosulfide, alkali metal hydrosulfide, alkaline earth metal hydrosulfide, alkali metal sulfide and alkaline earth metal sulfide; <1> ~ <4> 3. The synthesis method according to claim 1 , <6> The pH of the reaction medium in step c) is between 4 and 9 (for example between 5 and 8, preferably between 6 and 7.5, more particularly between 6.2 and 7.2); <1> ~ <5> 3. The synthesis method according to claim 1 , <7> the compound of formula (II) is selected from the group consisting of O-phospho-L-homoserine, O-succinyl-L-homoserine, O-acetyl-L-homoserine, O-acetoacetyl-L-homoserine, O-propio-L-homoserine, O-coumaroyl-L-homoserine, O-malonyl-L-homoserine, O-hydroxymethylglutaryl-L-homoserine, O-pimelyl-L-homoserine and O-sulfato-L-homoserine (preferably O-acetyl-L-homoserine); <1> ~ <6> 3. The synthesis method according to claim 1 , <8> the compound of formula (II) is O-acetyl-L-homoserine, the enzyme used is O-acetyl-L-homoserine sulfhydrylase, and the functionalized mercaptan of formula (I) is L-homocysteine; <1> ~ <7> 3. The synthesis method according to claim 1 , <9> The sulfhydrylase is a transferase of the EC2. type. <1> ~ <8> 3. The synthesis method according to claim 1 , <10> <1> and a compound of formula (II) as defined above a sulfhydrylase (preferably a sulfhydrylase related to the compound of formula (II) above); Excess ammonium hydrosulfide NH 4 SH or H 2 S and A composition (preferably a solution) comprising:

Claims

1. 1. A method for synthesizing at least one functionalized mercaptan of general formula (I): R 2 -X-C * H (NR 1 R 7 )-(CH 2 ) n -SH (I) [In the formula, R 1 and R 7 are the same or different and each is a hydrogen atom or an aromatic or non-aromatic linear, branched or cyclic, saturated or unsaturated hydrocarbon chain having 1 to 20 carbon atoms, which may contain one or more heteroatoms; X is -C(=O)-, -CH 2 - and -CN; R 2 teeth, (i) absent when X is -CN; (ii) is a hydrogen atom, (iii) -OR 3 Is it [R 3 is a hydrogen atom or an aromatic or non-aromatic, linear, branched or cyclic, saturated or unsaturated hydrocarbon chain having 1 to 20 carbon atoms, which may contain one or more heteroatoms; or (iv) -NR 4 R 5 [R 4 and R 5 are the same or different and each is a hydrogen atom or a saturated or unsaturated, aromatic or non-aromatic, linear, branched or cyclic hydrocarbon chain having 1 to 20 carbon atoms which may contain one or more heteroatoms; n is 1 or 2; * represents an asymmetric carbon. a) providing at least one compound of general formula (II): R 2 -X-C * H (NR 1 R 7 )-(CH 2 ) n -G (II) [In the formula, *, R 1 , R 2 , R 7 , X and n are as defined in formula (I); G is (i) R 6 -C(O)-O-, (ii) (R 7 O) (R 8 O)-P(O)-O-, or (iii) R 9 O-SO 2 represents —O—; 6 is a hydrogen atom or may contain one or more aromatic groups, -OR 10 , (=O), -C(O)OR 11 and -NR 12 R 13 R is a linear, branched or cyclic, saturated or unsaturated hydrocarbon chain having 1 to 20 carbon atoms, which may be substituted with one or more groups selected from 10 , R 11 , R 12 and R 13 are each independently H or a linear, branched or cyclic, saturated or unsaturated hydrocarbon chain having 1 to 20 carbon atoms; R 7 and R 8 are the same or different and each is a proton, an alkali metal, an alkaline earth metal, or ammonium, R 9 is selected from a proton, an alkali metal, an alkaline earth metal, and ammonium. b) at least one hydrosulfide salt and / or sulfide salt or H 2 providing S; c) reacting said at least one compound of formula (II) with said at least one hydrosulfide salt and / or sulfide salt or H 2S in the presence of at least one enzyme selected from sulfhydrylases, wherein the sulfhydrylase is of the EC 2.5.1.XX class; d) obtaining at least one functionalized mercaptan of formula (I); e) optionally isolating the at least one functionalized mercaptan of formula (I) obtained in step d); f) optionally further functionalizing and / or deprotecting said functionalized mercaptan of formula (I) obtained in step d) or e); Including, Steps a) and b) may be carried out simultaneously; Synthesis method.

2. Step c) is The reaction mixture is carried out in a reactor containing less than 0.0015% by weight of oxygen, based on the total weight of the reaction mixture; and / or carried out in a reactor in which the gas phase contained in the gas head space of the reactor contains less than 21% by volume of oxygen relative to the total volume of the gas phase; The synthesis method according to claim 1.

3. The hydrosulfide salt and / or sulfide salt or H 2 2. The method of claim 1, wherein S is in excess relative to the compound of formula (II).

4. Molar ratio [hydrosulfide salt and / or sulfide salt] / [compound of formula (II)], or molar ratio H 2 The synthesis method according to claim 1 or 2, wherein S / the compound of formula (II) is 1.5-10.

5. 5. The method of claim 1, wherein the at least one hydrosulfide salt and / or sulfide salt is selected from the group consisting of ammonium hydrosulfide, alkali metal hydrosulfide, alkaline earth metal hydrosulfide, alkali metal sulfide and alkaline earth metal sulfide.

6. The synthesis method according to any one of claims 1 to 5, wherein the pH of the reaction medium in step c) is between 4 and 9.

7. The method of any one of claims 1 to 6, wherein the compound of formula (II) is selected from the group consisting of O-phospho-L-homoserine, O-succinyl-L-homoserine, O-acetyl-L-homoserine, O-acetoacetyl-L-homoserine, O-propio-L-homoserine, O-coumaroyl-L-homoserine, O-malonyl-L-homoserine, O-hydroxymethylglutaryl-L-homoserine, O-pimelyl-L-homoserine and O-sulfato-L-homoserine.

8. The method of claim 7, wherein the compound of formula (II) is O-acetyl-L-homoserine.

9. A method of synthesis according to any one of claims 1 to 7, wherein the compound of formula (II) is O-acetyl-L-homoserine, the enzyme used is O-acetyl-L-homoserine sulfhydrylase and the functionalized mercaptan of formula (I) is L-homocysteine.

10. A compound of formula (II) as defined in claim 1; Sulfhydrylase, Excess ammonium hydrosulfide NH 4 SH or H 2 S. and A composition comprising: The sulfhydrylase is of the EC 2.5.1.XX class, Contains less than 0.0015% by weight of oxygen based on the total weight of the composition; The composition.